Purpose: Although valve ablation is the treatment of choice in patients with posterior urethral valves (PUV), temporary high (ureterostomy) diversion remains controversial. In this study we evaluated the effect of bilateral Sober high urinary diversion on renal and bladder function.
Materials And Methods: We retrospectively reviewed the records of 36 patients with PUV who underwent bilateral Sober-type diversion. Following valve ablation urodynamic studies were done in all patients after diversion and repeated after ureterostomy closure. The mean duration of diversion was 55 months. Vesicoureteral reflux (VUR), renal dysplasia, serum creatinine during followup and urodynamic parameters were recorded.
Results: All patients underwent endoscopic valve ablation. Renal function impairment at the end of followup was present in 15 patients. Renal dysplasia was found in 10 patients, while VUR was present in 16 at the time of the first urodynamic studies. Urodynamic studies after ureterostomy closure showed well preserved bladder capacity or compliance in 80% and 69% of cases, respectively. About a third of patients showed increased capacity and normal compliance. Univariate analysis showed that VUR, urinary tract infection and renal dysplasia significantly correlated with impaired renal function. On multivariate analysis renal dysplasia was an independent prognostic factor for poor prognosis.
Conclusions: In patients with PUV temporary high diversion of the Sober type does not have a negative influence on bladder function. It immediately releases high intrarenal pressures but only improves renal function temporarily and may contribute to postpone the time of end stage renal failure. Renal dysplasia dictates long-term renal outcomes in this group.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/01.ju.0000157326.62792.39 | DOI Listing |
Radiol Case Rep
March 2025
Department of Family Medicine, University of South Florida, Morsani College of Medicine, Tampa, FL, USA.
Eur J Med Genet
December 2024
Center for Medical Genetics, Keio University School of Medicine, Tokyo, Japan. Electronic address:
Cardiol Rev
October 2024
Barbra Streisand Women's Heart Center, Smidt Heart Institute, Cedars Sinai Medical Center, Los Angeles, CA.
Arterial hypertension in young adults, which includes patients between 19 and 40 years of age, has been increasing in recent years and is associated with a significantly higher risk of target organ damage and short-term mortality. It has been reported that up to 10% of these cases are due to a potentially reversible secondary cause, mainly of endocrine (primary aldosteronism, Cushing's syndrome, and pheochromocytoma/paraganglioma), renal (renovascular hypertension due to fibromuscular dysplasia and renal parenchymal disease), or cardiac (coarctation of the aorta) origin. It is recommended to rule out a secondary cause of high blood pressure (BP) in those patients with early onset of grade 2 or 3 hypertension, acute worsening of previously controlled hypertension, resistant hypertension, hypertensive emergency, severe target organ damage disproportionate to the grade of hypertension, or in the face of clinical or biochemical characteristics suggestive of a secondary cause of hypertension.
View Article and Find Full Text PDFFree Radic Biol Med
December 2024
Laboratory of Cellular and Molecular Biology (LBCM), Team Biotechnology and System Biology, Faculty of Biological Sciences, University of Sciences and Technology Houari Boumediene (USTHB), Bab-Ezzouar, Algiers, Algeria. Electronic address:
Oral squamous cell carcinoma (OSCC) is a disabling tumor with poor response to chemotherapy. Here, we sought to explore a new chemotherapeutic approach based on a combined induction of cytotoxic ROS and targeting of autophagy and aerobic glycolysis as central contributors to OSCC carcinogenesis and chemoresistance. To this end, tongue OSCC was generated in BALB/c mice using 4NQO.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!